SFM

Sphera Funds Management Portfolio holdings

AUM $479M
1-Year Est. Return 66.44%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+66.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$479M
AUM Growth
+$56.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
128
New
Increased
Reduced
Closed

Top Buys

1
+$9.19M
2
+$8M
3
+$7.87M
4
VOR icon
Vor Biopharma
VOR
+$7.64M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$6.59M

Top Sells

1
+$19M
2
+$18.2M
3
+$13.8M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$10.8M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$9.45M

Sector Composition

1 Healthcare 85.98%
2 Technology 11.47%
3 Industrials 1.25%
4 Communication Services 0%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSGN icon
101
Design Therapeutics
DSGN
$595M
– –
-21,918
ENGN icon
102
enGene Holdings
ENGN
$677M
– –
-504,409
ETNB
103
DELISTED
89bio
ETNB
– –
-39,675
IDYA icon
104
IDEAYA Biosciences
IDYA
$2.83B
– –
-100,000
IMNM icon
105
Immunome
IMNM
$2.41B
– –
-147,200
IMVT icon
106
Immunovant
IMVT
$5.64B
– –
-256,743
LRMR icon
107
Larimar Therapeutics
LRMR
$441M
– –
-260,385
META icon
108
Meta Platforms (Facebook)
META
$1.64T
– –
-3,924
MIST icon
109
Milestone Pharmaceuticals
MIST
$146M
– –
-820,000
MLTX icon
110
MoonLake Immunotherapeutics
MLTX
$1.24B
– –
-71,010
MRUS
111
DELISTED
Merus
MRUS
– –
0
NICE icon
112
Nice
NICE
$7.18B
– –
-157,400
ORA icon
113
Ormat Technologies
ORA
$6.3B
– –
-29,000
PCVX icon
114
Vaxcyte
PCVX
$8.86B
– –
-50,000
PRAX icon
115
Praxis Precision Medicines
PRAX
$9.34B
– –
-57,901
QQQ icon
116
Invesco QQQ Trust
QQQ
$397B
– –
-22,960
QURE icon
117
uniQure
QURE
$974M
– –
-24,900
ROIV icon
118
Roivant Sciences
ROIV
$20.7B
– –
-42,571
RZLT icon
119
Rezolute
RZLT
$307M
– –
-363,947
SABS icon
120
SAB Biotherapeutics
SABS
$195M
– –
-566,395
SRPT icon
121
Sarepta Therapeutics
SRPT
$1.76B
– –
0
TLT icon
122
iShares 20+ Year Treasury Bond ETF
TLT
$45.7B
– –
0
TVTX icon
123
Travere Therapeutics
TVTX
$2.67B
– –
0
XBI icon
124
State Street SPDR S&P Biotech ETF
XBI
$8.13B
– –
0
RAPP
125
Rapport Therapeutics
RAPP
$1.38B
– –
-157,533
2 3 4
5
6